The purpose of this study is to compare the efficacy and safety of titrated oral misoprostol solution with intravenous oxytocin for labor augmentation in women without adequate uterine contractions.
Numerous labor course necessitate augmentation when uterine contractions are inadequate. When the cervix is favorable, labor augmentation attempts are more likely to be successful. Augmentation is these women is traditionally undertaken with intravenous oxytocin and amniotomy, either alone or in combination. In our previous trial, it has been proven that the method of titrated oral misoprostol is associated with a lower incidence of uterine hyperstimulation and a lower cesarean delivery rate than vaginal misoprostol for labor induction in patients with unfavorable cervix. Because administering Misoprostol solution is easy and cost saving, it is worth to develop this novel method in labor augmentation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
143
Titrated Misoprostol Solution
Titrated Intravenous Oxytocin
Labor Unit, Department of Obstetric and Gynecology, China Medical Univertiy Hospital
Taichung, Taiwan
RECRUITINGthe percentage of women delivering infants vaginally within 12 hours of augmentation
Time frame: post vaginal delivery
uterine hyperstimulation rate
Time frame: post vaginal delivery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.